We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Digital Cell Application Assists in Recognition of Blood Cells

By LabMedica International staff writers
Posted on 17 Feb 2011
A new application for digital devices assists in the recognition and classification of blood cells, making it easier for university students and clinical laboratory personnel to learn the basics of cell morphology.

The CellAtlas new application of Apple iPhone and iPod Touch contains mini lectures in English written by experts in hematology. More...
The application gives the technologist access to high-resolution classified cell images complemented by a written description. The CellAtlas reference library provides laboratory personnel with images that can be compared quickly and easily to blood or body fluid cells they are viewing at a microscope.

CellaVision (Lund, Sweden), which develops and sells products for the routine analysis of blood and body fluids, introduced the new application for the Apple iPhone and iPod Touch devices to compliment its digital cell morphology portfolio.

CellQuiz is included in the application to test the user's knowledge in cell morphology. Additionally, the user will have access to links and media that will show how CellaVision systems and software can replace manual microscopy in the hematology lab by saving labor and improving quality.

"It is a pleasure to be able to present the clinical laboratory market with a CellaVision iPhone Application. CellAtlas is an excellent educational tool and reference library for laboratory personnel and students. By making the tool easily accessible we hope to get more laboratories interested in our digital solution for cell analysis,” says Yvonne Mårtensson, CellaVision's CEO.

Related Links:

CellaVision




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Automated Urinalysis Solution
UN-9000
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.